Skip to main content

Advertisement

SpringerLink
Log in

A Case of Severe Lead Encephalopathy with Cardiac Arrest Managed During a Chelation Shortage

  • Case Report
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Introduction

For many years, the standard of care in the USA has been to treat acute lead encephalopathy with a combination parenteral dimercaprol (BAL) and CaNa2EDTA. We present a case of a pediatric patient with severe lead encephalopathy, complicated by cardiac arrest, who was treated with an alternative regimen when CaNa2EDTA was unavailable.

Case Report

A 24-month-old male was brought by ambulance to an emergency department (ED) with new onset seizures and sustained a cardiac arrest. An initial blood lead concentration returned at 263 mcg/dl. The hospital was unable to obtain CaNa2EDTA due to the nationwide shortage. For this reason, the patient was chelated with BAL IM for 12 days and dimercaptosuccinic acid (DMSA) for 28 days. He received a second 5-day course of BAL due to rebounding blood lead concentrations. Eight days after cardiac arrest, he was extubated; however, despite ongoing therapy, subsequent follow-up 2 months later demonstrated persistent cognitive deficits.

Discussion

The combination of DMSA and BAL was effective in rapidly decreasing whole blood lead concentrations. Drug shortages continue to have implications for the management of poisoned patients. This case highlights how shortages of chelating agents complicate patient care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Arnold J, Morgan B. Management of lead encephalopathy with DMSA after exposure to lead-contaminated moonshine. J Med Toxicol. 2015;11(4):464–7. https://doi.org/10.1007/s13181-015-0493-9\.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Thurtle N, Greig J, Cooney L, Amitai Y, Ariti C, Brown MJ, et al. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data. PLoS Med. 2014;11(10) https://doi.org/10.1371/journal.pmed.1001739.

  3. Ennis JM, Harrison HE. Treatment of lead encephalopathy with bal(2.3-dimercaptopropanol). Pediatrics. 1950;5(5):853–68. https://doi.org/10.1542/peds.5.5.853.

    Article  CAS  PubMed  Google Scholar 

  4. Keshri S, Goel AK, Garg AK. Reversal of acute lead encephalopathy in a child. Cureus. 2021; https://doi.org/10.7759/cureus.15155.

  5. Chisolm JJ. The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood. J Pediatr. 1968;73(1):1–38. https://doi.org/10.1016/s0022-3476(68)80036-8.

    Article  CAS  PubMed  Google Scholar 

  6. Ryder HW, Cholak J, Kehoe RA. Influence of dithiopropanol (BAL) on human lead metabolism. Science. 1947;106(2742):63–4. https://doi.org/10.1126/science.106.2742.63.

    Article  CAS  PubMed  Google Scholar 

  7. Germuth F, Eagle H. The efficacy of BAL (2, 3-dimercaptopropanol) in the treatment of experimental lead poisoning in rabbits. J Pharmacol Exp Therap. 1948;92(4):397–410.

  8. Giannattasio R, Pirozzi M, Bedo A, Jennings K. Bal therapy in chronic lead poisoning. Pediatrics. 1952;10(5):603–11. https://doi.org/10.1542/peds.10.5.603.

    Article  CAS  PubMed  Google Scholar 

  9. Mazer-Amirshahi M, Fox ER, Routsolias JC, Johnson-Arbor K, Mycyk MB. How can we “get the lead out” without chelators? J Med Toxicol. 2021;17(4):330–2. https://doi.org/10.1007/s13181-021-00848-1.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Brown MJ, Willis T, Omalu B, Leiker R. Deaths resulting from hypocalcemia after administration of Edetate Disodium: 2003-2005. Pediatrics. 2006;118(2) https://doi.org/10.1542/peds.2006-0858.

  11. King AM, Danagoulian S, Lynch M, Menke N, Mu Y, Saul M, et al. The effect of a medical toxicology inpatient service in an academic tertiary care referral center. J Med Toxicol. 2018;15(1):12–21. https://doi.org/10.1007/s13181-018-0684-2.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Davis KM. Lead poisoning prevention efforts in high-risk environments: Follow-up testing rates among preschool children in Flint, Michigan, 2013–2015. J Racial Ethn Health Disparities. 2020;8(1):199–209. https://doi.org/10.1007/s40615-020-00772-0.

    Article  PubMed  Google Scholar 

  13. Neuwirth LS. Resurgent lead poisoning and renewed public attention towards environmental social justice issues: a review of current efforts and call to revitalize primary and secondary lead poisoning prevention for pregnant women, lactating mothers, and children within the U.S. Int J Occup Environ Health. 2018;24(3–4):86–100. https://doi.org/10.1080/10773525.2018.1507291.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Medical Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI, 53226, USA

    Damilola Idowu, Matthew Stanton & David Gummin

  2. Wisconsin Poison Center, PO Box 1997, Suite C660, Milwaukee, WI, 53226, USA

    Damilola Idowu, Matthew Stanton & David Gummin

  3. Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI, 53792, USA

    Zachary Gray

  4. Alabama Poison Information Center, 1600 7th Ave South, Birmingham, AL, 35233, USA

    William Rushton

Authors
  1. Damilola Idowu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zachary Gray
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew Stanton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William Rushton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David Gummin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Damilola Idowu.

Ethics declarations

Consent for publication of this case was obtained and provided to the journal in accordance with JMT policy.

Conflict of Interest

None

Additional information

Supervising Editor: Mark B. Mycyk, MD

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Idowu, D., Gray, Z., Stanton, M. et al. A Case of Severe Lead Encephalopathy with Cardiac Arrest Managed During a Chelation Shortage. J. Med. Toxicol. 20, 49–53 (2024). https://doi.org/10.1007/s13181-023-00970-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-023-00970-2

Search

Navigation